The main drivers of fatigue in patients with psoriasis and psoriatic arthritis were joint pain intensity, itch severity, and psoriasis severity. Researchers found an association between psoriasis, ...

Ventyx Biosciences is terminating most work on its lead drug candidate for inflammatory diseases despite achieving the main goal of a mid-stage study in plaque psoriasis. The results fall short of ...

Psoriasis can be alarming if you’re newly diagnosed. When you look at your patch (or patches) of thick, red skin, you probably want to know two things: How can I make this disappear? And how can I ...

“What is psoriasis?” might seem like a pretty straightforward question—it’s a skin condition that causes raised bumpy patches, right? Not quite, actually. Psoriasis is a chronic autoimmune condition ...

Susan Bard, MD, is a board-certified general and procedural dermatologist with the American Board of Dermatology and a Fellow of the American College of Mohs Surgery. Psoriasis is an autoimmune skin ...

Main Outcome Measures: Rate ratios (RRs) for marked improvement or clearance in patient and investigator overall assessments of response; mean difference in percentage change in Psoriasis Area and ...

(RTTNews) - Can-Fite BioPharma Ltd. (CANF) on Wednesday said Phase 3 COMFORT study of its drug candidate Piclidenoson for the treatment of moderate to severe plaque psoriasis met primary goal. Topline ...

Catching psoriasis early is vital for managing the disease effectively and minimizing its impact on your quality of life. Timely intervention can help slow disease progression, alleviate symptoms, and ...

BANGALORE, Sept 21 (Reuters) - Incyte Corp said its topical treatment INCB18424 for psoriasis met the main and secondary goals in a mid-stage trial, sending its shares up nearly 11 percent. "The ...